A new threshold regression model for survival data with a cure fraction

Lifetime Data Analysis

Volumn 17, Issue 1, 2011, Pages 101-122

  Kim, Sungduk ^a   Chen, Ming Hui ^b   Dey, Dipak K ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Cure rate models; DIC; Latent variables; LPML; Markov chain Monte Carlo; Posterior distribution; Prostate cancer

Indexed keywords

ARTICLE; BAYES THEOREM; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HUMAN; IMMUNOLOGY; MALE; MONTE CARLO METHOD; MORTALITY; PROBABILITY; PROSTATE TUMOR; REGRESSION ANALYSIS; STATISTICAL MODEL; SURVIVAL;

BAYES THEOREM; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; HUMANS; MALE; MARKOV CHAINS; MODELS, STATISTICAL; MONTE CARLO METHOD; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 78651468368     PISSN: 13807870     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10985-010-9166-9     Document Type: Article

References (42)

1. Berkson J, Gage RP (1952) Survival curve for cancer patients following treatment. J Am Stat Assoc 47: 501-515.
2. Broet P, Rycke YD, Tubert-Bitter P, Lellouch J, Asselain B, Moreau T (2001) A semiparametric approach for the two-sample comparison of survival times with long-term survivors. Biometrics 57: 844-852.
3. Chen M-H, Ibrahim JG (2001a) Maximum likelihood methods for cure rate models with missing covariates. Biometrics 57: 43-52.
4. Chen M-H, Ibrahim JG (2001b) Bayesian model comparisons for survival data with a cure fraction. In: Bayesian methods with applications to science, policy and official statistics. Office for Official Publications of the European Communities, Luxembourg, pp 81-90.
5. Chen M-H, Ibrahim JG, Sinha D (1999) A new Bayesian model for survival data with a surviving fraction. J Am Stat Assoc 94: 909-919.
6. Chen M-H, Ibrahim JG, Sinha D (2002a) Bayesian inference for multivariate survival data with a surviving fraction. J Multivar Anal 80: 101-126.
7. Chen M-H, Harrington DP, Ibrahim JG (2002b) Bayesian cure rate models for malignant melanoma: a case-study of Eastern Cooperative Oncology Group Trial E1690. Appl Stat 51(2): 135-150.
8. Cheng SC, Wei LJ, Ying Z (1995) Analysis of transformation models with censored data. Biometrika 82: 835-845.
9. Chi Y, Ibrahim JG (2006) Joint models for multivariate longitudinal and multivariate survival data. Biometrics 62: 432-445.
10. Clayton DG, Cuzick J (1986) The semi-parametric pareto model for regression analysis of survival times. In: Gill RD, Voors MN (eds) Papers on semiparametric models at the ISI centenary session, Report MS-R8169. Centre for Mathematics and Computer Science, Amsterdam, pp 19-30.
11. Cooner F, Banerjee S, Carlin BP, Sinha D (2007) Flexible cure rate modelling under latent activation schemes. J Am Stat Assoc 102: 560-572.
12. Cooner FW, Yu X, Banerjee S, Grambsch PL, McBean AM (2009) Hierarchical dynamic time-to-event models for post-treatment preventive care data on breast cancer survivors. Stat Modell 9: 119-135.
13. Cowles MK, Carlin BP (1996) Markov chain Monte Carlo convergence diagnostics: A comparative review. J Am Stat Assoc 91: 883-904.
14. Cox DR (1972) Regression models and life tables. J R Stat Soc Series B 34: 187-220.
15. Cuzick J (1988) Rank regression. Ann Stat 16: 1369-1389.
16. D'Amico AV, Renshaw AA, Sussman B, Chen M-H (2005) Pre-treatment PSA velocity and the risk of death from prostate cancer following external beam radiation therapy. J Am Med Assoc 294: 440-447.
17. Farewell VT (1982) The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 38: 1041-1046.
18. Farewell VT (1986) Mixture models in survival analysis: are they worth the risk?. Can J Stat 14: 257-262.
19. Fine JP (1999) Analysing competing risks data with transformation models. J R Stat Soc Series B 61: 817-830.
20. Gilks WR, Wild P (1992) Adaptive rejection sampling for Gibbs sampling. Appl Stat 41: 337-348.
21. Hastings WK (1970) Monte Carlo sampling methods using Markov chains and their applications. Biometrika 57: 97-109.
22. Ibrahim JG, Chen M-H, Sinha D (2001a) Bayesian semi-parametric models for survival data with a cure fraction. Biometrics 57: 383-388.
23. Ibrahim JG, Chen M-H, Sinha D (2001b) Bayesian survival analysis. Springer-Verlag, New York.
24. Ibrahim JG, Chen M-H, Sinha D (2005) Bayesian approaches to cure rate models. In: Armitage P, Colton T (eds) Encyclopedia of Biostatistics, 2nd edn, vol 1. Wiley, Chichester, pp 306-313.
25. Kim S, Chen M-H, Dey DK, Gamerman D (2007) Bayesian dynamic models for survival data with a cure fraction. Lifetime Data Anal 13: 17-35.
26. Kim S, Xi Y, Chen M-H (2009) A new latent cure rate marker model for survival data. Ann Appl Stat 3: 1124-1146.
27. Kuk AYC, Chen C-H (1992) A mixture model combining logistic regression with proportional hazards regression. Biometrika 79: 531-541.
28. Li C-S, Taylor JMG, Sy JP (2001) Identifiability of cure models. Stat Probab Lett 54: 389-395.
29. Liu JS (1994) The collapsed Gibbs sampler in Bayesian computations with applications to a gene regulation problem. J Am Stat Assoc 89: 958-966.
30. Lu W, Ying Z (2004) On semiparametric transformation cure models. Biometrika 91: 331-343.
31. Maller R, Zhou X (1996) Survival analysis with long-term survivors. Wiley, New York.
32. Meeker WQ (1987) Limited failure population life tests: application to integrated circuit reliability. Technometrics 29: 51-65.
33. Peng Y, Dear KBG (2000) A nonparametric mixture model for cure rate estimation. Biometrics 56: 237-243.
34. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A (2002) Bayesian measures of model complexity and fit (with discussion). J R Stat Soc Series B 64: 583-639.
35. Sy JP, Taylor JMG (2000) Estimation in a proportional hazards cure model. Biometrics 56: 227-336.
36. Tsodikov A (2001) Estimation of survival based on proportional hazards when cure is a possibility. Math Comput Model 33: 1227-1236.
37. Tsodikov A (2002) Semiparametric models of long- and short-term survival: an application to the analysis of breast cancer survival in Utah by age and stage. Stat Med 21: 895-920.
38. Tsodikov AD, Ibrahim JG, Yakovlev AY (2003) Estimating cure rates from survival data: an alternative to two-component mixture models. J Am Stat Assoc 98: 1063-1078.
39. Yakovlev AY, Tsodikov AD (1996) Stochastic models of tumor latency and their biostatistical applications. World Scientific, New Jersey.
40. Yakovlev AY, Asselain B, Bardou VJ, Fourquet A, Hoang T, Rochefediere A, Tsodikov AD (1993) A simple stochastic model of tumor recurrence and its applications to data on premenopausal breast cancer. In: Asselain B, Boniface M, Duby C, Lopez C, Masson JP, Tranchefort J (eds) Biometrie et Analyse de Dormees Spatio-Temporelles, 12. Société Francaise de Biométrie, ENSA Rennes, France, pp 66-82.
41. Yin G, Ibrahim JG (2005a) A general class of Bayesian survival models with zero and nonzero cure fractions. Biometrics 61: 403-412.
42. Yin G, Ibrahim JG (2005b) Cure rate models: a unified approach. Can J Stat 33: 559-570.